Search This Blog

Monday, April 1, 2019

Amneal Pharmaceuticals agrees with Zentiva to divest Creo Pharma

Amneal Pharmaceuticals announced that it has entered into an agreement with Zentiva Group, under which Zentiva has acquired Creo Pharmaceuticals, a subsidiary of Amneal that operates the company’s commercial operations in the United Kingdom.

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.